Literature DB >> 3011305

Effects of anti-promoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells.

S M Fischer, J K Baldwin, L M Adams.   

Abstract

The induction of oxidant production in mouse epidermal cells by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) can be suppressed by many, but not all, known inhibitors of mouse skin tumor promotion. Members of the anti-oxidant category that were tested were ranked in the following order, 7,8-benzoflavone greater than butylated hydroxyanisole greater than ascorbic acid. In the retinoid category, retinoic acid was only moderately effective, while the trimethoxymethylphenyl analog had at least twice the inhibitory activity. Among the six protease inhibitors examined, tosylphenylalanine chloromethylketone and tosyllysine chloromethylketone were effective in diminishing the response while tosylarginine methylester, antipain, leupeptin and soybean trypsin inhibitor were ineffective, suggesting that proteases are probably not involved in the oxidant response. Several agents, trifluoperazine, trisialoganglioside and diolein, that have been shown to suppress TPA activity in other cell systems were also found to suppress the oxidant response. Finally, the extent of the oxidant response was found to correlate with sensitivity to TPA tumor promotion among the three strains of mice tested: SSIn greater than SENCAR greater than C57BL/6J.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011305     DOI: 10.1093/carcin/7.6.915

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  Evidence that Gsta4 modifies susceptibility to skin tumor development in mice and humans.

Authors:  Erika L Abel; Joe M Angel; Penny K Riggs; Laura Langfield; Herng-Hsiang Lo; Maria D Person; Yogesh C Awasthi; Li-E Wang; Sara S Strom; Qingyi Wei; John DiGiovanni
Journal:  J Natl Cancer Inst       Date:  2010-10-21       Impact factor: 13.506

3.  Reactive oxygen in the tumor promotion stage of skin carcinogenesis.

Authors:  S M Fischer; G S Cameron; J K Baldwin; D W Jasheway; K E Patrick
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

4.  Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles.

Authors:  R L Shapiro; J G Duquette; I Nunes; D F Roses; M N Harris; E L Wilson; D B Rifkin
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

5.  Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model.

Authors:  M Viluksela
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

6.  Production of hydrogen peroxide by cutaneous T-cell lymphoma following photopheresis with psoralens and ultraviolet light.

Authors:  D E Heck; E Bisaccia; S Armus; J D Laskin
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Molecular mechanisms of mouse skin tumor promotion.

Authors:  Joyce E Rundhaug; Susan M Fischer
Journal:  Cancers (Basel)       Date:  2010       Impact factor: 6.639

8.  A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.

Authors:  Sachini U Siriwardena; Madusha L W Perera; Vimukthi Senevirathne; Jessica Stewart; Ashok S Bhagwat
Journal:  Mol Cell Biol       Date:  2018-12-11       Impact factor: 5.069

9.  Inflammation, oxidative DNA damage, and carcinogenesis.

Authors:  J G Lewis; D O Adams
Journal:  Environ Health Perspect       Date:  1987-12       Impact factor: 9.031

Review 10.  Response modification in carcinogenesis.

Authors:  P A Cerutti
Journal:  Environ Health Perspect       Date:  1989-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.